<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03899116</url>
  </required_header>
  <id_info>
    <org_study_id>101-2018</org_study_id>
    <nct_id>NCT03899116</nct_id>
  </id_info>
  <brief_title>Gradual Deflation of Thigh Tourniquet for Attenuation of Hemodynamic Post-tourniquet Response in Old Patients</brief_title>
  <official_title>Gradual Deflation of Thigh Tourniquet for Attenuation of Hemodynamic Post-tourniquet Response in Old Patients :Randomized Control Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Deflation of the pneumatic tourniquet used in lower limb surgery is usually associated with
      hemodynamic instability, metabolic and respiratory changes. These changes are usually
      tolerated by young, healthy patients; However, these complications are risky for elderly and
      cardiac patients. The aim of this study is to assess the effect of gradual deflation of thigh
      tourniquet on the hemodynamics and arterial blood gases compared to the usual practice
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pneumatic tourniquet will be applied on the mid- thigh with cuff pressure of 350 mm Hg. After
      the end of surgery, the lower limb will be elevated at 45-degree and the patients will
      randomized into one of the three groups:

      G 50 (n=30) : The tourniquet cuff pressure will be deflated gradually by 50 mm Hg every 2
      minutes till complete deflation.

      G 100 (n=30): The tourniquet cuff pressure will be deflated gradually by 100 mm Hg every 2
      minutes till complete deflation.

      G 0 (n=30): The tourniquet cuff will be released till complete deflation. If hypotension is
      observed during the procedure, it will be managed by 10 mg ephedrine.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2019</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>mean arterial blood pressure</measure>
    <time_frame>15 minutes after start of deflation of cuff</time_frame>
    <description>The lowest mean arterial blood pressure during a 15-minute period after starting deflation of the tourniquet.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hypotension</measure>
    <time_frame>15 minutes after start of deflation of cuff</time_frame>
    <description>incidence of post tourniquet hypotension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cardiac output</measure>
    <time_frame>15 minutes after start of deflation of cuff</time_frame>
    <description>cardiac output after starting deflation using non invasive electrical cardiometry</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">81</enrollment>
  <condition>Tourniquet</condition>
  <arm_group>
    <arm_group_label>G50</arm_group_label>
    <description>The tourniquet cuff pressure will be deflated gradually by 50 mm Hg every 2 minutes till complete deflation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>G100</arm_group_label>
    <description>The tourniquet cuff pressure will be deflated gradually by 100 mm Hg every 2 minutes till complete deflation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>G0</arm_group_label>
    <description>The tourniquet cuff will be released till complete deflation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>deflation of pneumatic tourniquet</intervention_name>
    <description>gradual deflation with variable degrees</description>
    <arm_group_label>G0</arm_group_label>
    <arm_group_label>G100</arm_group_label>
    <arm_group_label>G50</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients above 50 years scheduled for orthopedic lower limb surgery under pneumatic
        tourniquet
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  scheduled for elective orthopedic lower limb surgery under pneumatic tourniquet

        Exclusion Criteria:

          -  BMI â‰¥35Kg/ m2

          -  patients with unstable angina, left ventricular dysfunction , cerebrovascular disease
             ,bleeding disorders

          -  contraindication to tourniquet insertion

          -  patients requiring massive intraoperative blood transfusion (Blood loss more than 50%
             of the patients' blood volume (70 ml/Kg) ).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>yasmin ibrahim</last_name>
    <phone>01006719987</phone>
    <email>yalnaby@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cairo university</name>
      <address>
        <city>Cairo</city>
        <zip>115711</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <contact>
      <last_name>yasmin ibrahim</last_name>
      <phone>1006719987</phone>
      <email>yalnaby@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>March 6, 2019</study_first_submitted>
  <study_first_submitted_qc>March 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2019</study_first_posted>
  <last_update_submitted>July 24, 2019</last_update_submitted>
  <last_update_submitted_qc>July 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Yasmin Hassab elnaby</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

